1.Kuwait Cancer Control Center, Laboratory of Cancer Genetics, Department of Hematology, Shuwaikh, 70653, Kuwait2.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Review on t(1;19)(p13;p13.1), with data on clinics.
Table 1. Reported patients with der(1)t(1;19)(p13;p13.1) Abbreviations: F, female; M, male; AML, Acute myeloid leukemia; MDS, myelodysplastic syndrome; post PV-MF, post polycytemic myelofibrosis
Sex
Age
Chromosomal anomalies
Diagnosis
Reference
1
M
36
40-46,XY,+der(1)t(1;19)(p13;p13.1)
AML-M1
Ma et al; 2000
2
F
47,XX,+der(1)t(1;19)(p13;p13.1),der(10)inv(10)(p2?5q25)t(10;11)(q25;q25),der(11)t(10;11)
AML- M5a
Tchinda et al; 2002
3
21
47,XX,+der(1)t(1;19)(p13;p13.1)
MDS
4
60
Suh et al; 2009
5
77
Post PV-MF
Adriana Zamecnikova ; Adriana Zamecnikova
t(1;19)(p13;p13.1)
Atlas Genet Cytogenet Oncol Haematol. 2015-06-01
Online version: http://atlasgeneticsoncology.org/haematological/1230/t(1;19)(p13;p13-1)
2002-04-01 t(1;19)(p13;p13.1) by Jean-Loup Huret  Affiliation